Deconvolution of Insulin Secretion, Insulin Hepatic Extraction Post-hepatic Delivery Rates and Sensitivity during 24-hour Standardized Meals: Time Course of Glucose Homeostasis in Leptin Replacement Treatment

Abstract

Minimally invasive methodology, mathematical model, and software for analysis of glucose homeostasis by deconvolution of insulin secretion, hepatic extraction, post-hepatic delivery, and sensitivity from 24-hour standardized meals test have been developed and illustrated by the study of glucose homeostasis of a genetically based leptin-deficient patient before and after leptin replacement treatment. The only genetically leptin-deficient adult man identified in the world was treated for 24 months with recombinant methionyl human leptin. Blood was collected every 7 minutes for 24 hours, with standardized meals consumed during the 4 visits: at baseline, one-week, 18-months, and 24-months after initiation of the treatment. Concentrations of insulin, C-peptide, and plasma glucose were measured. Insulin secretion was obtained by deconvolution of C-peptide data. Hepatic insulin extraction was determined based on our modifications of the insulin kinetics model. Insulin sensitivity for each of the four meals was calculated by using the minimal glucose model approach. Hepatic extraction of insulin was the first element of glucose homeostasis to respond to leptin replacement treatment and increased 2-fold after one week of treatment. Insulin secretion and delivery rates decreased more than 2-fold and insulin sensitivity increased 10-fold after 24 months of treatment. Computer programs for analysis of 24-hour insulin secretion, extraction, delivery, and action are available upon request.

Key words

mathematical modeling - C-peptide - hepatic extraction - insulin action

References

• 1 Friedman JM. Obesity in the new millennium.  Nature. 2000;  404 632-634
• 2 Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Metabolic syndrome and the endocrine stress system.  Horm Metab Res. 2006;  38 437-441
• 3 Yudkin JS. Inflammation, obesity and the metabolic syndrome.  Horm Metab Res. 2007;  39 707-709
• 4 Reimann M, Schutte AE, Schwarz PEH. Insulin resistance – the role of ethnicity: evidence from Caucasian and African cohorts.  Horm Metab Res. 2007;  39 853-857
• 5 Fischer-Posovsky , Wabitsch M, Hochberg Z. Endocrinology of adipose tissue. An update.  Horm Metab Res. 2007;  39 314-321
• 6 Guevara R, Valle A, Gianotti M, Roca P, Oliver J. Gender-dependent differences in serum profiles of insulin and leptin in caloric restricted rats.  Horm Metab Res. 2008;  40 38-43
• 7 Toffolo GM, Cobelli C. Insulin modelling. In: Carson E, Cobelli C, eds. Modelling methodology for physiology and medicine. San Diego: Academic Press 2001: 305-335
• 8 Caumo A, Simeoni M, Cobelli C. Glucose modeling. In: Carson E, Cobelli C, eds. Modelling methodology for physiology and medicine. San Diego: Academic Press 2001: 337-372
• 9 Mari A. Mathematical modeling in glucose metabolism and insulin secretion.  Curr Opin Clin Nutr Metab Care. 2002;  5 495-501
• 10 Mari A, Nielsen LL, Nanayakkara N, DeFronzo RA, Ferrannini E, Halseth A. Mathematical modeling shows exanatide improved beta-cell functions in patients with type 2 diabetes treated with metformin or metformin and sulfonylurea.  Horm Metab Res. 2006;  38 838-844
• 11 Makroglou A, Li J, Kuang Y. Mathematical models and software tools for the glucose-insulin regulatory system and diabetes: an overview.  App Num Math. 2006;  56 559-573
• 12 Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index.  J Clin Endocrinol Metab. 2000;  85 4396-4402
• 13 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue.  Nature. 1994;  372 425-432
• 14 Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance.  FASEB J. 2002;  16 1163-1176
• 15 Licinio J, Caglayan S, Ozata M, Yildiz BO, Miranda PB de, O’Kirwan F, Whitby R, Liang L, Cohen P, Bhasin S, Krauss RM, Veldhuis JD, Wagner AJ, DePaoli AM, MacCann SM, Wong M-L. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults.  Proc Natl Acad Sci USA. 2004;  101 4531-4536
• 16 Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.  J Clin Endocrinol Metab. 1980;  51 520-528
• 17 Toffolo G, Bergman RN, Finegood DT, Bowden CR, Cobelli C. Quantitative estimation of beta cell sensitivity to glucose in the intact organism. A minimal model of insulin kinetics in the dog.  Diabetes. 1980;  29 979-990
• 18 Polonsky KS, Given BD, Pugh W, Licinio-Paixao J, Thompson JE, Karrison T, Rubenstein AH. Calculation of systemic delivery rate of insulin in normal man.  J Clin Endocrinol Metab. 1986;  63 113-118
• 19 Cauter E van, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.  Diabetes. 1992;  41 368-377
• 20 Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.  J Clin Invest. 1986;  77 98-105
• 21 Vicini P, Caumo A, Cobelli C. The hot IVGTT two-compartment minimal model: index of glucose effectiveness and insulin sensitivity.  Am J Physiol Endocrinol Metab. 1997;  273 1024-1032
• 22 Man CD, Caumo A, Basu R, Rizza R, Toggolo G, Cobelli C. Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.  Am J Physiol Endocrinol Metab. 2004;  287 E637-E643
• 23 Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats.  Endocrinology. 1997;  138 3395-3401
• 24 Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin deficient diabetes in the rat.  Diabetes. 1999;  48 1487-1492
• 25 Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.  Proc Natl Acad Sci USA. 1996;  93 14804-14808
• 26 Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin.  Science. 1996;  274 1185-1188
• 27 Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes.  J Biol Chem. 1997;  272 10585-10593
• 28 Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting GLUT4 translocation in L6 rat skeletal muscle cells.  Endocrinology. 2001;  142 4806-4812
• 29 Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.  Nature. 2002;  415 339-343
• 30 Minokoshi Y, Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle.  Biochem Soc Trans. 2003;  31 196-201
• 31 Ceddia RB, William  Jr  WN, Curi R. Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation.  Int J Obes Relat Metab Disord. 1999;  23 75-82
• 32 Harris RB. Acute and chronic effects of leptin on glucose utilization in lean mice.  Biochem Biophys Res Commun. 1998;  245 502-509
• 33 Berti L, Kellerer M, Capp E, Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect.  Diabetologia. 1997;  40 606-609
• 34 Bates SH, Gardiner JV, Jones RB, Bloom SR, Bailey CJ. Acute stimulation of glucose uptake by leptin in L6 muscle cells.  Horm Metab Res. 2002;  34 111-115
• 35 Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment.  Nature. 1997;  389 374-377
• 36 Ceddia RB. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis.  Int J Obesity. 2005;  29 1175-1183
• 37 Pliquett RU, Fuhrer D, Falk S, Zysset S, Cramon DY von, Stumvoll M. The effects of insulin on the central nervous system- focus on appetite regulation.  Horm Metab Res. 2006;  38 442-446
• 38 Lee JH, Chan JL, Sourlas E, Raptopoulos V, Mantzoros CS. r-metHuLeptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy (HAART).  J Clin Endocrinol Metab. 2006;  91 2605-2611
• 39 Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Leptin-replacement therapy for lipodystrophy.  N Engl J Med. 2002;  346 570-578
• 40 Shapiro A, Matheny M, Zhang Y, Tumer N, Cheng K-Y, Rogrigues E, Zolotukhin S, Scarpace PJ. Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats.  Diabetes. 2008;  57 614-622
• 41 Oliveira E, Fagundes ATS, Alves SB, Pazos-Moura CC, Moura EG, Passos MCF, Lisboa PC. Chronic leptin treatment inhibits liver mitochondrial α-glycerol-β-phosphate dehydrogenase in euthyroid rats.  Horm Metab Res. 2007;  39 867-870

Clinical trial registry number: NCT00657605

Correspondence